Search results
Alvotech and Teva’s Selarsdi™ (ustekinumab-aekn), Biosimilar to Stelara® Approved by FDA | JD Supra
JD Supra· 2 days agoThe companies announced in June 2023 that they had reached a settlement and license agreement with Johnson & Johnson, which granted a license entry date for Selarsdi™ in the U.S. by February ...
20 Fastest Growing Health Tech Companies in the World
Insider Monkey via Yahoo Finance· 17 hours agoIn this article, we will be taking a look at the 20 fastest growing health tech companies in the...
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
Zacks via Yahoo Finance· 7 days agoJ&J Begins Q1 Earnings Season: J&J’s first-quarter results were mixed as it beat estimates for...
Analyst updates Johnson & Johnson stock price target after earnings
TheStreet via Yahoo Finance· 7 days ago“While sequential growth was roughly flat due to phasing, we continue to anticipate...
Stock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review
Investor's Business Daily· 7 days agoAbbott's EPS declined 5%, while J&J's rose 12%. Abbott beat sales forecasts, but issued light...
What Are the Most Effective Psoriasis Therapy Options?
Verywell Health via Yahoo News· 2 days agoWith many treatment options for psoriasis, how do you know which ones are right for you? Here are...
The Zacks Analyst Blog Highlights NVIDIA, Alphabet, Johnson & Johnson, Broadridge Financial and...
Zacks via Yahoo Finance· 7 days agoPer the Zacks analyst, headwinds like generic competition and pricing pressure continue to ail. The...
FDA requires changes to CAR-T cell therapy boxed warning (NYSE:BMY)
Seeking Alpha· 7 days agoThe FDA has mandated updates to safety information for CAR-T cell therapies due to a severe risk of...
5 Crash-Proof Stocks to Buy Immediately
InvestorPlace· 4 days agoIn February, I recommended five one-month momentum plays to buy as Bitcoin (BTC-USD) prices surged. The world’s largest cryptocurrency is a surprisingly...
Alvotech/Teva bring new partner to expand access for Humira biosimilar in U.S. (ALVO)
Seeking Alpha· 7 days agoAlvotech (ALVO) in agreement with Teva Pharmaceuticals (TEVA), signed a long-term agreement with a strategic partner to further enhance access to Adalimumab-ryv in US market.